US FDA approves remdesivir to treat non-hospitalised Covid-19 patients
The US FDA has also expanded the emergency use authorisation of remdesivir to include the treatment of non-hospitalised…
Amgen’s Lumakras approved in Japan to treat KRAS G12c-mutation positive NSCLC
21 Jan 22The MHLW approval was based on positive data from the Phase 2 CodeBreaK 100, a first-in-human, open-label multicentre…
Sputnik V shows superior antibody levels against Omicron variant
21 Jan 22People who received two doses of Sputnik V showed high levels of antibodies against Omicron than those vaccinated…
UCB to acquire epilepsy drugmaker Zogenix for up to $1.9bn
20 Jan 22The transaction will add Fintepla (fenfluramine), approved by the US Food and Drug Administration (FDA) and the European…
Biotechnology firm Altos Labs launches with $3bn funding
20 Jan 22Altos team contain scientists, clinicians, and leaders from both academia and industry, jointly working on reversing disease, injury,…
AstraZeneca’s STRIDE regimen shows positive survival outcomes in liver cancer trial
19 Jan 22The combination also showed no increase in severe liver toxicity and fewer discontinuations due to treatment-related adverse events…
Engitix raises $54m funding, collaborates with Dompé
19 Jan 22The Series A financing round was jointly led by existing investor Netherton Investments, alongside new investor Dompé farmaceutici
Gennova working on Omicron-specific mRNA Covid-19 vaccine
18 Jan 22The company has submitted the Phase 2 trial data for its mRNA vaccine candidate to India’s Central Drugs…
ADC Therapeutics, MTPC partner to develop Zynlonta in Japan
18 Jan 22ADC Therapeutics will receive an upfront payment of $30m, and up to $205m in milestone payments, in addition…
Pfizer’s JAK1 inhibitor Cibinqo approved in US to treat atopic dermatitis
17 Jan 22Cibinqo is an oral, once-daily, oral small molecule that selectively inhibits Janus kinase 1 (JAK1), to modulate multiple…